[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients].

Cremerius, U; Fabry, U; Kröll, U; Zimny, M; Neuerburg, J; Osieka, R; Büll, U

[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]. / Klinische Wertigkeit der FDG-PET zur Therapiekontrolle bei malignen Lymphomen--Ergebnisse einer retrospektiven Studie an 72 Patienten.

Cremerius, U; Fabry, U; Kröll, U; Zimny, M; Neuerburg, J; Osieka, R; Büll, U.

Affiliation

Cremerius U; Kliniken für Nuklearmedizin, RWTH Aachen, Deutschland.

Nuklearmedizin ; 38(1): 24-30, 1999.

Article in De | MEDLINE | ID: mdl-9987778

Subject(s)

Fluorodeoxyglucose F18; Lymphoma/diagnostic imaging; Lymphoma/therapy; Radiopharmaceuticals; Adolescent; Adult; Aged; Biopsy; Female; Hodgkin Disease/diagnostic imaging; Hodgkin Disease/therapy; Humans; L-Lactate Dehydrogenase/blood; Lymphoma/pathology; Lymphoma, Non-Hodgkin/diagnostic imaging; Lymphoma, Non-Hodgkin/therapy; Male; Middle Aged; Monitoring, Physiologic; Tomography, Emission-Computed; Tomography, X-Ray Computed

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radiopharmaceuticals / Fluorodeoxyglucose F18 / Lymphoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: De Journal: Nuklearmedizin Year: 1999 Document type: Article

Search on Google

XML

PubMed Links